Research Article | Open Access
Claudia Silva, Crispín Zavala-Alvarado, José L. Puente, "Self-Conjugation of the Enteropathogenic Escherichia coli Adherence Factor Plasmid of Four Typical EPEC Isolates", BioMed Research International, vol. 2017, Article ID 6325736, 7 pages, 2017. https://doi.org/10.1155/2017/6325736
Self-Conjugation of the Enteropathogenic Escherichia coli Adherence Factor Plasmid of Four Typical EPEC Isolates
The enteropathogenic Escherichia coli (EPEC) adherence factor plasmid (pEAF) encodes the proteins involved in the biogenesis of the bundle-forming pilus (BFP), a key virulence factor that mediates microcolony formation and the localized adherence phenotype on the surface of the host enterocytes. The presence or absence of this plasmid defines typical EPEC (tEPEC) and atypical EPEC (aEPEC), respectively. Although lateral transfer of pEAF has been evidenced by phylogenetic studies, conjugal transfer ability has been experimentally established only for two pEAF plasmids from strains isolated in the late 60s. In the present work, we tested the self-conjugation ability of four pEAF plasmids from tEPEC strains isolated between 2007 and 2008 from children in Peru and the potential of aEPEC to receive them. A kanamycin resistance cassette was inserted into donor pEAF plasmids in order to provide a selectable marker in the conjugation experiments. Two aEPEC isolated from the same geographic region were used as recipient strains along with the laboratory E. coli DH5α strain. Here we show that the four pEAF plasmids tested are self-conjugative, with transfer frequencies in the range of 10−6 to 10−9. Moreover, the generation of aEPEC strains harboring pEAF plasmids provides valuable specimens to further perform functional studies.
Escherichia coli is gamma Proteobacteria that colonizes the gastrointestinal tract of humans and other animals [1, 2]. Enteropathogenic E. coli (EPEC) is a leading cause of infantile diarrhea in developing countries . EPEC infection is accompanied by a distinct intestinal histopathology, called attaching and effacing (A/E) lesion, characterized by the intimate adherence of bacteria to enterocytes, the formation of actin-rich pedestals underneath the sites of bacterial attachment, and localized destruction of the brush border microvilli . The genes necessary for the establishment of the A/E lesion are located within the pathogenicity island known as the locus of enterocyte effacement (LEE) .
EPEC is classified into typical (tEPEC) and atypical (aEPEC) strains based on the presence of a large virulence plasmid known as EPEC adherence factor plasmid (pEAF) [1, 6, 7]. The pEAF encodes the bundle-forming pilus (BFP) that mediates EPEC autoaggregation and microcolony formation on the surface of epithelial cells, a phenotype known as localized adherence [8–11], as well as dispersion of the bacteria through the intestinal mucosa and virulence in adult volunteers [12–14]. BFP biogenesis is specified by the 14-gene bfp operon [15, 16].
Although the pEAF is not essential for the formation of the A/E lesion , it enhances their efficiency by promoting localized adherence on the host cell and the expression of LEE genes through the per regulatory operon, which consists of three genes, perA, perB, and perC. PerA activates the expression of the bfp operon and autoactivates its own expression [18–22]. PerC increases the expression of LEE encoded proteins by enhancing the activation of the LEE-encoded regulator (Ler) [20, 23–25].
The pEAF from prototype strains B171 (O111:NM), isolated in Washington in 1983 , and E2348/69 (O127:H6), isolated in Tauton, UK, in 1969 , has been fully sequenced. The most conspicuous difference between these two pEAF plasmids is the presence of conjugal transfer (tra) genes on E2348/69 pMAR7, a derivative of the wild-type pMAR2 marked with a Tn801 transposon conferring resistance to ampicillin [8, 28], but not in the B171 pEAF, pB171 . However, the rest of the two plasmids are highly conserved, and they share the genetic organization of bfp and per operons, and three plasmid replication and maintenance regions (repFIIA, repFIB, and stb-par-rsv-ccd) [28, 29]. The presence of tra genes in other pEAF has been determined by Southern-blot hybridization  and genome sequence analysis of tEPEC strains of different phylogenomic lineages , but their conjugation ability was not tested experimentally. To our knowledge the E2348/69 pMAR7 and E2347/69 pDEP1, both strains isolated from the same outbreak and belonging to serotype O127:H6, are the only pEAF plasmids for which conjugative transfer ability has been demonstrated [8, 31, 32].
The aim of this work was to test the self-conjugation ability of four EAF plasmids from tEPEC strains isolated between 2007 and 2008 from children in Peru  and the potential of two aEPEC strains isolated from the same geographic region to incorporate them when used as recipient strains in conjugation experiments.
2. Materials and Methods
2.1. EPEC Strains
The EPEC strains used in this work were isolated in 2007-2008, as part of an epidemiological surveillance program in suburban areas of Lima, Peru . Based on the presence of EAF plasmid markers (see below) four tEPEC strains were selected as pEAF plasmid donors, and two aEPEC strains as recipients. E. coli DH5α was also included as a recipient strain (Table 1).
2.2. PCR Detection of pEAF Genes
Based on available pEAF sequences, primers specific for the amplification of the repFIIA replication region and of two distant regions within the tra operon (traI and traC genes, encoding for the relaxase, and an ATPase required for pilus production of the type IV secretion system, respectively), were designed using the primers4clades web server  (Table 2). For the detection of the bfp operon, the bfpA sequence was amplified using the primers described by Lacher et al. . DNA was extracted from liquid cultures by a modification of the salt extraction method described by Miller et al. (1988) . Amplifications were performed in 50 μl reactions using a commercial Taq polymerase kit (Thermo scientific) and 1.5 U Taq polymerase per tube, with a final concentration of 1.5 mM MgCl, 0.2 mM dNTPs, and 0.5 μM each primer. Two μL of extracted total DNA was used as a template (roughly 50 ng). The cycling program was as follows: 5 min 95°C followed by 30 cycles of 45 s at 94°C, 30 s at 57°C, and 45 s at 72°C and completed by a final extension for 5 minutes at 72°C.
2.3. Insertion of a Kanamycin Resistance Cassette into pEAF
We used the Lambda Red Recombinase system  to insert the kanamycin resistance cassette () carried in pKD4 into the pEAF ISSfl1 locus of the four selected strains (Table 1) using the recombinase function carried on pKD78. The ISSfl1 locus was selected since this was the target for the insertion of the ampicillin resistance Tn801 transposon in EPEC E2348/69 pMAR7 . The K1 and K2 primers in combination with the IS-F and IS-R primers were used to confirm the correct insertion of the kanamycin resistance cassette into ISSfl1 (Table 2).
2.4. Conjugation Experiments
The strains carrying the pEAF-derivatives marked with the kanamycin resistance cassette were used as donors in mating experiments (Table 1). E. coli DH5α and two Peruvian aEPEC strains (D3319 and D3264) were used as recipients. Strains D3264 and DH5α were , and a spontaneous colony was selected for D3319. In order to avoid the selection of spontaneous donor strains instead of transconjugants during the conjugation experiments, spontaneous rifampicin resistant () colonies of the donor strains were selected to have a second antibiotic resistance selection marker. Therefore, the and recipient strains were named DH5αRN, D3319RN and D3264RN (Table 1). Conjugation experiments were performed as follows: 5 ml LB overnight liquid cultures of donor and recipient strains were pelleted, washed and resuspended in 1 ml of sterile water, mixed in a 1 : 10 donor-to-recipient ratio (50 : 500 μl), platted onto nonselective solid LB plates, and incubated overnight at 37°C. The conjugation mix was removed from the LB plate with 1 ml of sterile water, and transconjugants were selected by plating 100 μl of serial dilutions onto solid LB medium supplemented with kanamycin (60 μg/ml) to evaluate the number of donors, or rifampicin (100 μg/ml), nalidixic acid (30 μg/ml), and kanamycin (60 μg/ml) to quantify the number of transconjugants. Conjugation frequencies were calculated as the ratio of number of transconjugants (, , )/number of donor strains (). Each conjugation experiment was repeated at least twice. The presence of the pEAF plasmid was confirmed by bfpA PCR analysis of ten transconjugant colonies per experiment (Table 2).
To corroborate the self-conjugation ability of the pEAF plasmids, the purified plasmid from a transconjugant colony derived from the first conjugation event was transformed by electroporation into DH5α using kanamycin as selection marker. Transformant colonies were checked by PCR amplification of bfpA. A transformant DH5α strain harboring the pEAF was used as donor in further conjugation experiments using DH5αRN as the recipient strain (Figure 1(a)).
2.5. Plasmid Profiling
To analyze the plasmid content of selected isolates, a modified protocol of the alkaline lysis procedure proposed by Kieser was used . The products were separated in 0.7% agarose gels in 1x TBE buffer at 100 volts for 4 hours, stained with a 1% ethidium bromide solution, and photographed.
3.1. tEPEC Strains D0131, D3152, D3048, and D3129 Contain pEAF and Conjugative Transfer Markers
EPEC isolates D0131, D3152, D3048, and D3129, previously reported as tEPEC  (Table 1), were selected to analyze the conjugative transfer ability of their pEAF plasmids, which were positive for bfpA, repFIIA, traI, and traC genes based on PCR amplification using specific primers (data not shown). This observation suggested that these plasmids are potentially conjugative. aEPEC strains D3319 and D3264 were selected as recipient strains (Table 1).
3.2. The pEAF Plasmids Were Successfully Marked with a Kanamycin Resistance Cassette
In order to assess the conjugation ability of the pEAF plasmids of tEPEC strains D0131, D3152, D3048, and D3129, these were marked with a kanamycin resistance cassette, since the E. coli virulence plasmids rarely carry antibiotic resistance genes [40, 41]. The region selected for its insertion was the IS element ISSfl1, located downstream of the per operon, because it was the target sequence for the Tn801 transposon inserted in EPEC E2348/69 derivative pMAR7, which was demonstrated not to affect the pEAF adherence functions . The pEAF plasmids of these strains were successfully marked and their derivatives were referred to as pD0131::km, pD3152::km, pD3048::km, and pD3129::km, respectively (Table 1).
For the conjugation experiments aEPEC recipient strains D3319 and D3264 were chosen, as well as the E. coli laboratory strain DH5α. For the three recipient strains spontaneous colonies were selected to obtain a second resistance marker to counter-select the sensitive donor strains. These and recipient strains were referred to as D3319RN, D3264RN, and DH5αRN (Table 2).
3.3. The pEAF Plasmids Are Self-Conjugative
The conjugation experiments showed, in agreement with the presence of tra genes, that all four tEPEC strains successfully transferred their pEAF plasmids to the three recipient strains. The transfer frequencies were low in the range between 10−6 and 10−9 (Table 3). No consistent differences in transfer frequencies among recipient strains were observed. Our results demonstrate that pEAF plasmids from different tEPEC strains, other than the prototype, are able to self-conjugate to other E. coli strains.
|The experiments were repeated at least twice. and nalidixic acid resistant derivatives.|
In order to confirm the self-conjugation ability of the pEAF plasmids, the transconjugant plasmids from mating experiments between strain D0131 pD0131::km and D3264RN, and strain D3129 pD3129::km and D3319RN, were transformed into DH5α. The DH5α transformant strains carrying pD0131::km or pD3129::km were used as donors in a second conjugation experiment with DH5αRN as the recipient strain (Figure 1(a)). The conjugation frequencies for DH5α pD0131::km were in the range of 1.5 × 10−6 to 6.7 × 10−8 and for DH5α pD3129::km in the range of 1.1 to 5.1 × 10−6. Transconjugant colonies were positive for bfpA amplification. Plasmid profiles for the conjugation experiments of strain D0131 showed that a plasmid of about 100 kb was transferred to both D3319RN and DH5αRN (Figure 1(b)). Of note, purified pD0131::km from the second-generation D3319RN transconjugant (Figure 1(b), lane 5) looks slightly shorter than that from the first-generation D3319RN transconjugant (Figure 1(b), lane 3), which could be indicative of loss of genetic material during the conjugation process. However, taken together, these results demonstrate that the pEAF plasmids contain the complete molecular machinery for self-conjugation irrespective of the E. coli donor genetic background.
In this study, we report that the pEAF plasmids from four tEPEC strains isolated in 2007-2008 from children in Peru are self-conjugative. To our knowledge, self-conjugation ability has been reported only for the highly similar pMAR7 and pDEP1 pEAF plasmids from two EPEC O127:H6 isolates [31, 32]. For tEPEC strain B171 (O111:NM), Riley et al. (1987) initially reported that it was able to transfer localized adherence and antibiotic resistance phenotypes ; however, sequence studies showed that the B171 pEAF does not carry tra genes , and later Nwaneshiudu et al. (2007) demonstrated that the transfer of the adherent and antibiotic resistance phenotypes was due to the mobilization of B171 pEAF by a conjugative antimicrobial resistance plasmid . The pEAF of our strains were tra positive, and subsequent mating experiments supported their self-conjugation (Table 3 and Figure 1).
Our experiments also demonstrate that aEPEC strains can receive the pEAF. These transconjugant strains are suitable candidates for studying the effect of the introduction of the pEAF into aEPEC genetic backgrounds, as well as its stability under laboratory conditions considering that pEAF instability has previously been reported [30, 44, 45]. Future research will also be conducted to analyze the functional responses and gene expression profiles of these aEPEC pEAF-carrying strains, including the expression of BFP and the localized adherence phenotype, as well as the regulatory effect of the per locus over the LEE island. In this regard, recent global transcriptional analyses have demonstrated that pEAF genes influence the expression of a number of chromosomal genes in addition to the LEE [30, 46].
Studies tracing the evolution of EPEC have provided phylogenetic evidence for the multiple gain and loss of the pEAF virulence plasmids [30, 47–49]. Although our mating experiments show low conjugation frequencies (10−6 to 10−9), the present study provides experimental evidence for the self-conjugation of pEAF virulence plasmids between E. coli strains, supporting the role of pEAF transfer in EPEC ecology and evolution.
In this study four tEPEC strains were challenged for conjugation of their pEAF virulence plasmids. All the pEAF plasmids were able to self-conjugate into three E. coli recipient strains including a laboratory strain, with transfer frequencies ranging from of 10−6 to 10−9. In a second-generation experiment, two of the transconjugant pEAF plasmids were able to conjugate even from a non-EPEC genetic background (DH5α), indicating that these plasmids fully possess the ability for lateral transfer. Moreover, the generation of transconjugant aEPEC strains harboring pEAF plasmids provides valuable specimens to further perform functional response analysis.
The current address of Crispín Zavala-Alvarado is Unit of Biology of Spirochetes, Department of Microbiology, Institute Pasteur, Paris, France.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
This work was supported by DGAPA IN213516 and CONACyT 239659 and FC-2015-2/950 to José L. Puente. Claudia Silva was supported by FC-2015-2/879. The authors are grateful to Theresa J. Ochoa from Universidad Peruana Cayetano Heredia for kindly providing the EPEC strains. They acknowledge the technical assistance of Alejandra Vázquez, Marcos Fernández-Mora, Francisco J. Santana, and Javier Rivera and thank the Unidad de Síntesis y Secuenciación of the Instituto de Biotecnología, UNAM.
- J. B. Kaper, J. P. Nataro, and H. L. T. Mobley, “Pathogenic Escherichia coli,” Nature Reviews Microbiology, vol. 2, no. 2, pp. 123–140, 2004.
- M. A. Croxen and B. B. Finlay, “Molecular mechanisms of Escherichia coli pathogenicity,” Nature Reviews Microbiology, vol. 8, no. 1, pp. 26–38, 2010.
- T. J. Ochoa and C. A. Contreras, “Enteropathogenic Escherichia coli infection in children,” Current Opinion in Infectious Diseases, vol. 24, no. 5, pp. 478–483, 2011.
- Y. Lai, I. Rosenshine, J. M. Leong, and G. Frankel, “Intimate host attachment: enteropathogenic and enterohaemorrhagic Escherichia coli,” Cellular Microbiology, vol. 15, no. 11, pp. 1796–1808, 2013.
- J. S. Pearson, C. Giogha, T. Wong Fok Lung, and E. L. Hartland, “The Genetics of Enteropathogenic Escherichia coli Virulence,” Annual Review of Genetics, vol. 50, pp. 493–513, 2016.
- R. T. Hernandes, W. P. Elias, M. A. M. Vieira, and T. A. T. Gomes, “An overview of atypical enteropathogenic Escherichia coli,” FEMS Microbiology Letters, vol. 297, no. 2, pp. 137–149, 2009.
- L. R. Trabulsi, R. Keller, and T. A. Tardelli Gomes, “Typical and atypical enteropathogenic Escherichia coli,” Emerging Infectious Diseases, vol. 8, no. 5, pp. 508–513, 2002.
- M. Baldini, J. Kaper, M. Levine, and H. Moon, “Molecular nature of adhesion in enteropathogenic escherichia coli,” Journal of Pediatric Gastroenterology and Nutrition, vol. 2, no. 3, pp. 534–538, 1983.
- J. P. Nataro, K. O. Maher, P. Mackie, and J. B. Kaper, “Characterization of plasmids encoding the adherence factor of enteropathogenic Escherichia coli,” Infection and Immunity, vol. 55, no. 10, pp. 2370–2377, 1987.
- J. P. Nataro, I. C. A. Scaletsky, J. B. Kaper, M. M. Levine, and L. R. Trabulsi, “Plasmid-mediated factors conferring diffuse and localized adherence of enteropathogenic Escherichia coli,” Infection and Immunity, vol. 48, no. 2, pp. 378–383, 1985.
- J. A. Girôn, A. S. Y. Ho, and G. K. Schoolnik, “An inducible bundle-forming pilus of enteropathogenic Escherichia coli,” Science, vol. 254, no. 5032, pp. 710–713, 1991.
- S. Knutton, R. K. Shaw, R. P. Anantha, M. S. Donnenberg, and A. A. Zorgani, “The type IV bundle-forming pilus of enteropathogenic Escherichia coli undergoes dramatic alterations in structure associated with bacterial adherence, aggregation and dispersal,” Molecular Microbiology, vol. 33, no. 3, pp. 499–509, 1999.
- R. M. Hyland, J. Sun, T. P. Griener et al., “The bundlin pilin protein of enteropathogenic Escherichia coli is an N-acetyllactosamine-specific lectin,” Cellular Microbiology, vol. 10, no. 1, pp. 177–187, 2008.
- D. Bieber, S. W. Ramer, C.-Y. Wu et al., “Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic escherichia coli,” Science, vol. 280, no. 5372, pp. 2114–2118, 1998.
- K. D. Stone, H.-Z. Zhang, L. K. Carlson, and M. S. Donnenberg, “A cluster of fourteen genes from enteropathogenic Escherichia coli is sufficient for the biogenesis of a type IV pilus,” Molecular Microbiology, vol. 20, no. 2, pp. 325–337, 1996.
- I. Sohel, J. L. Puente, S. W. Ramer, D. Bieber, C.-Y. Wu, and G. K. Schoolnik, “Enteropathogenic Escherichia coli: Identification of a gene cluster coding for bundle-forming pilus morphogenesis,” Journal of Bacteriology, vol. 178, no. 9, pp. 2613–2628, 1996.
- S. Knutton, M. M. Baldini, J. B. Kaper, and A. S. McNeish, “Role of plasmid-encoded adherence factors in adhesion of enteropathogenic Escherichia coli to HEp-2 cells,” Infection and Immunity, vol. 55, no. 1, pp. 78–85, 1987.
- V. H. Bustamante, E. Calva, and J. L. Puente, “Analysis of cis-acting elements required for bfpA expression in enteropathogenic Escherichia coli,” Journal of Bacteriology, vol. 180, no. 11, pp. 3013–3016, 1998.
- T. Tobe, G. K. Schoolnik, I. Sohel, V. H. Bustamante, and J. L. Puente, “Cloning and characterization of bfpTVW, genes required for the transcriptional activation of bfpA in enteropathogenic Escherichia coli,” Molecular Microbiology, vol. 21, no. 5, pp. 963–975, 1996.
- O. G. Gomez-Duarte and J. B. Kaper, “A plasmid-encoded regulatory region activates chromosomal eaeAexpression in enteropathogenic Escherichia coli,” Infection and Immunity, vol. 63, no. 5, pp. 1767–1776, 1995.
- Y. Martínez-Laguna, E. Calva, and J. L. Puente, “Autoactivation and environmental regulation of bfpT expression, the gene coding for the transcriptional activator of bfpA in enteropathogenic Escherichia coli,” Molecular Microbiology, vol. 33, no. 1, pp. 153–166, 1999.
- M. E. Porter, P. Mitchell, A. J. Roe, A. Free, D. G. E. Smith, and D. L. Gally, “Direct and indirect transcriptional activation of virulence genes by an AraC-like protein, PerA from enteropathogenic Escherichia coli,” Molecular Microbiology, vol. 54, no. 4, pp. 1117–1133, 2004.
- V. H. Bustamante, M. I. Villalba, V. A. García-Angulo et al., “PerC and GrlA independently regulate Ler expression in enteropathogenic Escherichia coli,” Molecular Microbiology, vol. 82, no. 2, pp. 398–415, 2011.
- M. E. Porter, P. Mitchell, A. Free, D. G. E. Smith, and D. L. Gally, “The LEE1 promoters from both enteropathogenic and enterohemorrhagic Escherichia coli can be activated by PerC-like proteins from either organism,” Journal of Bacteriology, vol. 187, no. 2, pp. 458–472, 2005.
- V. Bueris, J. Huerta-Cantillo, F. Navarro-Garcia, R. M. Ruiz, A. M. Cianciarullo, and W. P. Elias, “Late establishment of the attaching and effacing lesion caused by atypical enteropathogenic Escherichia coli depends on protein expression regulated by Per,” Infection and Immunity, vol. 83, no. 1, pp. 379–388, 2015.
- M. Levine, D. Nalin, R. Hornick et al., “Escherichia coli strains that cause diarrhœa but do not produce heat-labile or heat-stable enterotoxins and are non-invasive,” The Lancet, vol. 311, no. 8074, pp. 1119–1122, 1978.
- J. Taylor, “Infectious infantile enteritis, yesterday and today,” Proceedings of the Royal Society of Medicine, vol. 63, no. 12, pp. 1297–1301, 1970.
- C. Brinkley, V. Burland, R. Keller et al., “Nucleotide sequence analysis of the enteropathogenic Escherichia coli adherence factor plasmid pMAR7,” Infection and Immunity, vol. 74, no. 9, pp. 5408–5413, 2006.
- T. Tobe, T. Hayashi, C.-G. Han, G. K. Schoolnik, E. Ohtsubo, and C. Sasakawa, “Complete DNA sequence and structural analysis of the enteropathogenic Escherichia coli adherence factor plasmid,” Infection and Immunity, vol. 67, no. 10, pp. 5455–5462, 1999.
- T. H. Hazen, J. B. Kaper, J. P. Nataro, and D. A. Raskoa, “Comparative genomics provides insight into the diversity of the attaching and effacing escherichia coli virulence plasmids,” Infection and Immunity, vol. 83, no. 10, pp. 4103–4117, 2015.
- L. Beutin, O. Marchés, K. A. Bettelheim et al., “HEp-2 cell adherence, actin aggregation, and intimin types of attaching and effacing Escherichia coli strains isolated from healthy infants in Germany and Australia,” Infection and Immunity, vol. 71, no. 7, pp. 3995–4002, 2003.
- M. M. McConnell, H. Chart, S. M. Scotland, H. R. Smith, G. A. Willshaw, and B. Rowe, “Properties of adherence factor plasmids of enteropathogenic Escherichia coli and the effect of host strain on expression of adherence to HEp-2 cells,” Journal of General Microbiology, vol. 135, no. 5, pp. 1123–1134, 1989.
- T. J. Ochoa, L. Ecker, F. Barletta et al., “Age-related susceptibility to infection with diarrheagenic Escherichia coli among infants from periurban areas in Lima, Peru,” Clinical Infectious Diseases, vol. 49, no. 11, pp. 1694–1702, 2009.
- B. Contreras-Moreira, B. Sachman-Ruiz, I. Figueroa-Palacios, and P. Vinuesa, “primers4clades: A web server that uses phylogenetic trees to design lineage-specific PCR primers for metagenomic and diversity studies,” Nucleic Acids Research, vol. 37, no. 2, pp. 95–100, 2009.
- D. W. Lacher, H. Steinsland, T. E. Blank, M. S. Donnenberg, and T. S. Whittam, “Molecular evolution of typical enteropathogenic Escherichia coli: Clonal analysis by multilocus sequence typing and virulence gene allelic profiling,” Journal of Bacteriology, vol. 189, no. 2, pp. 342–350, 2007.
- S. A. Miller, D. D. Dykes, and H. F. Polesky, “A simple salting out procedure for extracting DNA from human nucleated cells,” Nucleic Acids Research, vol. 16, no. 3, article 1215, 1988.
- S. G. N. Grant, J. Jessee, F. R. Bloom, and D. Hanahan, “Differential plasmid rescue from transgenic mouse DNAs into Escherichia coli methylation-restriction mutants,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 87, no. 12, pp. 4645–4649, 1990.
- K. A. Datsenko and B. L. Wanner, “One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 97, no. 12, pp. 6640–6645, 2000.
- T. Kieser, “Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli,” Plasmid, vol. 12, no. 1, pp. 19–36, 1984.
- T. J. Johnson and L. K. Nolan, “Pathogenomics of the virulence plasmids of Escherichia coli,” Microbiology and Molecular Biology Reviews, vol. 73, no. 4, pp. 750–774, 2009.
- J. P. Nataro, J. B. Kaper, R. Robins-Browne, V. Prado, P. Vial, and M. M. Levine, “Patterns of adherence of diarrheagenic escherichia coli to HEp-2 cells,” The Pediatric Infectious Disease Journal, vol. 6, no. 9, pp. 829–831, 1987.
- L. W. Riley, L. N. Junio, L. B. Libaek, and G. K. Schoolnik, “Plasmid-encoded expression of lipopolysaccharide O-antigenic polysaccharide in enteropathogenic escherichia coli,” Infection and Immunity, vol. 55, no. 9, pp. 2052–2056, 1987.
- A. I. Nwaneshiudu, T. Mucci, D. J. Pickard, and I. N. Okeke, “A second large plasmid encodes conjugative transfer and antimicrobial resistance in O119:H2 and some typical O111 enteropathogenic Escherichia coli strains,” Journal of Bacteriology, vol. 189, no. 16, pp. 6074–6079, 2007.
- M. S. Donnenberg, C. O. Tacket, S. P. James et al., “Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection,” The Journal of Clinical Investigation, vol. 92, no. 3, pp. 1412–1417, 1993.
- M. M. Levine, J. P. Nataro, H. Karch et al., “The diarrheal response of humans to some classic serotypes of enteropathogenic escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor,” The Journal of Infectious Diseases, vol. 152, no. 3, pp. 550–559, 1985.
- J. L. Mellies, A. Platenkamp, J. Osborn, and L. Ben-Avi, “PerC manipulates metabolism and surface antigens in enteropathogenic Escherichia coli,” Frontiers in Cellular and Infection Microbiology, vol. 7, article no. 32, 2017.
- T. H. Hazen, J. W. Sahl, C. M. Fraser, M. S. Donnenberg, F. Scheutz, and D. A. Rasko, “Refining the pathovar paradigm via phylogenomics of the attaching and effacing Escherichia coli,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 110, no. 31, pp. 12810–12815, 2013.
- S. D. Reid, C. J. Herbelin, A. C. Bumbaugh, R. K. Selander, and T. S. Whittam, “Parallel evolution of virulence in pathogenic Escherichia coli,” Nature, vol. 406, no. 6791, pp. 64–67, 2000.
- M. S. Donnenberg and T. S. Whittam, “Pathogenesis and evolution of virulence in enteropathogenic and enterohemorrhagic Escherichia coli,” The Journal of Clinical Investigation, vol. 107, no. 5, pp. 539–548, 2001.
Copyright © 2017 Claudia Silva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.